Varian Halcyon Treatment System Receives Taiwan FDA Approval

PALO ALTO, Calif., Jan. 8, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced its Halcyon™ system has received Taiwan FDA approval, which allows the company to market this new cancer treatment system in Taiwan. This appr... Devices, Oncology, Regulatory Varian Medical Systems, Halcyon, IMRT, radiotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news